EO-1022

N/A

Report date: 2025/04/18 09:42:03

Base Information

Drug NameEO-1022
Drug Alias NameEO-1022EO122
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payload
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 modulatorsTubulin polymerisation inhibitors
TargetsReceptor tyrosine-protein kinase erbB-3Tubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElevation Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesElevation Oncology Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A